| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 278,933 | 367,111 | 804,645 | 607,163 | | Cost of Revenue | 463,467 | (92,814) | 603,918 | 430,067 | | | Gross Profit | (184,534) | 459,925 | 200,727 | 177,096 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (295,151) | 328,180 | 20,372 | 18,762 | | Non Recurring | 1,804 |
-
|
-
| 182,811 | | Others | 45,695 | 43,659 | 41,714 | 42,342 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 64,922 | 88,086 | 138,641 | (66,819) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,535 | 1,836 | 1,762 | 7,219 | | Earnings Before Interest And Taxes | 67,104 | 90,837 | 141,089 | (60,286) | | Interest Expense | 24,546 | 24,295 | 20,394 | 17,681 | | Income Before Tax | 42,558 | 66,542 | 120,695 | (77,967) | | Income Tax Expense | 15,560 | 23,638 | 47,211 | (35,289) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,998 | 42,904 | 73,484 | (42,678) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,998 | 42,904 | 73,484 | (42,678) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,998 | $42,904 | $73,484 | ($42,678) |
|
1.52% Nasdaq 
Income Statement
